<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01958762</url>
  </required_header>
  <id_info>
    <org_study_id>PI2013_843_0010</org_study_id>
    <secondary_id>2013-A00606-39</secondary_id>
    <nct_id>NCT01958762</nct_id>
  </id_info>
  <brief_title>Screening for Cancers in the Oral CAvity</brief_title>
  <acronym>IDECAB</acronym>
  <official_title>Screening for Cancers in the Oral CAvity Targeting Tobacco Users in Somme, France</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire, Amiens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Picardy - Regional health agency (ARS)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Regional Council Picardie</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Regional Observatory of Health and Social Issues in Picardie (OR2S)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Association for the screening of diseases in Somme (Adema 80)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Somme Cancer Registry</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire, Amiens</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In the Somme region of France, cancer registry data showed an increasing incidence of oral
      cancer. The Incidence Rates in Somme as compared to the national rates for Lip, Oral Cavity
      and Pharynx Cancer were in 2010: 31,4/100 000 Standard population versus 18,2 /100 000 for
      male and 8,2/100 000 versus 5,5/100 000 for female, disaster area where action to improve
      early detection for smokers will be assessed. This target population consults late (as 70% of
      oral cavity cancers are diagnosed at a late stage (T3 or T4). This project is an innovative
      incentive strategy for screening among general practitioners based on unusual information
      vectors (tobacconist, local media).

      The main objective of this study is a screening of oral cavity cancers in tobacco users aged
      30-75 years in the Somme region of France.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Methodology:

        -  Education and alerting physicians to the early detection of cancers of oral cavity and
           coordination of networks involved for 1 year.

        -  Incentive period for the screening by the tobacconist who distributes with every package
           of cigarettes bought a flyer of invitation to the screening.

        -  Carrying out screening examinations by general practitioners with completion of the
           customized examination forms, orientation towards a specialist, data collection and
           evaluation.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Participation rate to the screening of the target patients.</measure>
    <time_frame>03 months after the start of the incentive period</time_frame>
    <description>Numbers of people who benefit from a screening exam by a physician of the Somme region in comparison, with the target population of the Somme region. This rate will be also calculated according the different of age and sex.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The participation rate of the physicians.</measure>
    <time_frame>03 months after the start of the incentive period</time_frame>
    <description>Number of physicians who send back at least one clinical form compared to the numbers of physician of the Somme.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The participation rate of the tobacco venders.</measure>
    <time_frame>15 days after the start of the incentive period</time_frame>
    <description>The number of tobacco venders who gave at least 01 &quot; Flyer &quot; in comparison to the numbers of tobacco venders of the Somme.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Oral Cavity Cancer</condition>
  <arm_group>
    <arm_group_label>Screening for cancers in the oral cavity</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Invitation for oral cavity cancer screening</intervention_name>
    <arm_group_label>Screening for cancers in the oral cavity</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any smoker who buys a pack of cigarettes over a period of two weeks in a tobacco shop
             located on the territory of the Somme

          -  lives in somme departement

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bernard DEVAUCHELLE, MD, phD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Amiens University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bernard DEVAUCHELLE, MD, phD</last_name>
    <phone>033 3 22 66 83 25</phone>
    <email>devauchelle.bernard@chu-amiens.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Stéphanie DAKPE, MD</last_name>
    <phone>033 3 22 66 83 25</phone>
    <email>dakpe.stephanie@chu-amiens.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Amiens University Hospital</name>
      <address>
        <city>Amiens</city>
        <state>Picardie</state>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stéphanie DAKPE, MD</last_name>
      <phone>0033 3 22 66 83 25</phone>
      <email>ddakpe.stephanie@chu-amiens.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Amiens University Hospital</name>
      <address>
        <city>Amiens</city>
        <state>Picardie</state>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bernard DEVAUCHELLE, MD, phD</last_name>
      <phone>0033 3 22 66 83 25</phone>
      <email>devauchelle.bernard@chu-amiens.fr</email>
    </contact>
    <investigator>
      <last_name>Stéphanie DAKPE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>http://www.cepidc.vesinet.inserm.fr/</citation>
  </reference>
  <reference>
    <citation>Bailey EE, Marghoob AA, Orengo IF, Testa MA, White VR, Geller AC. Skin cancer knowledge, attitudes, and behaviors in the salon: a survey of working hair professionals in Houston, Texas. Arch Dermatol. 2011 Oct;147(10):1159-65. doi: 10.1001/archdermatol.2011.184.</citation>
    <PMID>22006132</PMID>
  </reference>
  <reference>
    <citation>Subramanian S, Sankaranarayanan R, Bapat B, Somanathan T, Thomas G, Mathew B, Vinoda J, Ramadas K. Cost-effectiveness of oral cancer screening: results from a cluster randomized controlled trial in India. Bull World Health Organ. 2009 Mar;87(3):200-6.</citation>
    <PMID>19377716</PMID>
  </reference>
  <reference>
    <citation>Epstein JB, Silverman S Jr, Epstein JD, Lonky SA, Bride MA. Analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue. Oral Oncol. 2008 Jun;44(6):538-44. Epub 2007 Nov 8. Erratum in: Oral Oncol. 2008 Jun;44(6):615.</citation>
    <PMID>17996486</PMID>
  </reference>
  <reference>
    <citation>Hubert A, Lapôtre B, Raverdy N, Ganry O. Incidence et mortalité 2002-2004 Evolution de 1982 à 2004. Registre du Cancer de la Somme. Juin 2009. 138 p.</citation>
  </reference>
  <reference>
    <citation>Réseau Francim, service de biostatistique des hospices civils de Lyon. Survie des patients atteints de Cancer en France : étude des registres du réseau Francim, Paris 2007, springer, 406</citation>
  </reference>
  <reference>
    <citation>Reyt E, Righini C. Les cancers du plancher buccal. La chirurgie mini-invasive. Société française de carcinologie cervico-faciale.EDK</citation>
  </reference>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 7, 2013</study_first_submitted>
  <study_first_submitted_qc>October 7, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 9, 2013</study_first_posted>
  <last_update_submitted>April 25, 2016</last_update_submitted>
  <last_update_submitted_qc>April 25, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Screening</keyword>
  <keyword>Cancer</keyword>
  <keyword>Tobacco</keyword>
  <keyword>General Practitioner</keyword>
  <keyword>Precancerous Lesion</keyword>
  <keyword>Dysplasia</keyword>
  <keyword>Tobacco vendor</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mouth Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

